Skip to main content
  1. Home
  2. Emerging Tech
  3. Outdoors
  4. News

Farming robot uses sonar to spot fruit and even count individual leaves

Add as a preferred source on Google

A lot about farming hasn’t changed in a long time. But courtesy of new technologies like autonomous tractors and robot apple pickers, that may not stay true for much longer.

A new project, currently being developed by researchers at Israel’s Institute of Agricultural Engineering and Tel Aviv University, hints at another potential breakthrough in agriculture: a way to more accurately project future fruit yields — and it does so using sonar.

Recommended Videos

What researchers, led by Dr. Avital Bechar, are working on is an automated “AGRYbot” sonar system, described as a “robotic sonar for yield assessment and plant status evaluation.” In short, it’s a robot mounted with a sonar system, able to identify the different acoustic signatures of objects on an agricultural plot. And it’s pretty darn accurate.

By sending out sound waves and then analyzing them using smart algorithms, Dr. Bechar told Digital Trends that AGRYbot is able to recognize not just the difference between fruit trees and greenhouses, for example, but the difference between the leaves of a plant and the fruit that it potentially carries.

It can even reportedly provide accurate readings of the number of leaves on a tree, or the weight of its fruit — to within 100 grams.

“Up until now, farmers were working out this information on a hunch, or with not particularly accurate estimating tools like using the naked eye to look at a small sample,” Bechar told us. “We’ve found that these can result in up to 50 percent errors. Compared to that, our technology gives us very high accuracy with regards to the weight and yield of a plot. In addition, we can pinpoint the exact locations in a plot that give more or less yield, so that the reason for this can be examined.”

At present, Bechar’s team has a working prototype capable of operating both indoors and outdoors. It is hoped that a production line model will be available within the next several years.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more